After one year, people taking a GLP-1 drug had better outcomes than those taking an SGLT-2 drug. Specifically, they were 36% less likely to die from any cause, 12% less likely to be hospitalized, 22% ...
A simple formula developed at VCU two decades ago has become a global standard for liver disease detection, helping millions ...
Individuals with atrial fibrillation (Afib), or irregular heart rhythm, are at increased risk of stroke, chronic kidney ...
Wearables are best at noticing breaks from your body's usual patterns. Those outliers can hint that something warrants ...
The premise is straightforward — we are awash in biological data. The rapid growth of multiomics datasets (genomics, transcriptomics, proteomics, metabolomics, and radiomics) together with ...
India has made remarkable progress in controlling infectious liver diseases like hepatitis, but another threat has quietly ...
July 1, 2026 expert reaction to study looking at blood pressure and cholesterol levels in adults with obesity versus in adults with normal BMI . A study published in The Lancet lo ...
Jessica Nave, MD, vice president for middle revenue cycle at Emory Healthcare and assistant professor of medicine in Emory’s division of hospital medicine, both in Atlanta, summarized the updated 2025 ...
BAY COUNTY, Fla. (WMBB) – For millions of Americans, atrial fibrillation (AFib) can increase their risk of stroke, heart ...
Patients experiencing life-threatening diabetic ketoacidosis (DKA) require quick action, diligent care and close monitoring ...
Amarin Corporation plc (NASDAQ: AMRN) , a company committed to advancing the science of cardiovascular disease worldwide, applauds the recent FDA approval of injectable apolipoprotein C-III (APOC3) ...
Global health experts have updated the definition and guidelines for heart failure to address its rising prevalence. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results